Omnicell Net Worth
Omnicell Net Worth Breakdown | OMCL |
Omnicell Net Worth Analysis
Omnicell's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Omnicell's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Omnicell's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Omnicell's net worth analysis. One common approach is to calculate Omnicell's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Omnicell's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Omnicell's net worth. This approach calculates the present value of Omnicell's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Omnicell's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Omnicell's net worth. This involves comparing Omnicell's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Omnicell's net worth relative to its peers.
To determine if Omnicell is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Omnicell's net worth research are outlined below:
| Omnicell generated a negative expected return over the last 90 days | |
| Omnicell has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Omnicell says CFO Etta to step down |
Omnicell Quarterly Good Will |
|
Omnicell uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Omnicell. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Omnicell's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Omnicell's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Omnicell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Omnicell backward and forwards among themselves. Omnicell's institutional investor refers to the entity that pools money to purchase Omnicell's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | D. E. Shaw & Co Lp | 2024-12-31 | 940.6 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 873.5 K | Federated Hermes Inc | 2024-12-31 | 787.7 K | Royal Bank Of Canada | 2024-12-31 | 712.2 K | Bank Of New York Mellon Corp | 2024-12-31 | 639.8 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-12-31 | 639.5 K | Charles Schwab Investment Management Inc | 2024-12-31 | 616.2 K | Northern Trust Corp | 2024-12-31 | 565 K | Millennium Management Llc | 2024-12-31 | 499.8 K | Blackrock Inc | 2024-12-31 | 8.2 M | Vanguard Group Inc | 2024-12-31 | 5.6 M |
Follow Omnicell's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.54 B.Market Cap |
|
Project Omnicell's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.02 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
When accessing Omnicell's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Omnicell's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Omnicell's profitability and make more informed investment decisions.
Evaluate Omnicell's management efficiency
At this time, Omnicell's Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 0.01 this year, although the value of Return On Capital Employed will most likely fall to 0.0002. At this time, Omnicell's Other Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 297.7 M this year, although the value of Intangibles To Total Assets will most likely fall to 0.23. Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 27.00 | 28.35 | |
| Tangible Book Value Per Share | 6.96 | 7.30 | |
| Enterprise Value Over EBITDA | 6.1 K | 6.4 K | |
| Price Book Value Ratio | 1.65 | 1.57 | |
| Enterprise Value Multiple | 6.1 K | 6.4 K | |
| Price Fair Value | 1.65 | 1.57 | |
| Enterprise Value | 1.8 B | 1.6 B |
Omnicell showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 1.3877 | Revenue | Quarterly Revenue Growth 0.186 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omnicell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omnicell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omnicell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Omnicell Corporate Filings
8K | 12th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 27th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Omnicell Earnings per Share Projection vs Actual
Omnicell Corporate Management
| Joseph Spears | Principal Chief Accounting Officer | Profile | |
| Kathleen Nemeth | Senior Relations | Profile | |
| Vicki MacDevitt | Chief Staff | Profile | |
| Sara Dalmasso | Senior International | Profile | |
| Minoo Mortazavi | Senior Operations | Profile | |
| Corey Manley | Executive Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.558 | Earnings Share 0.27 | Revenue Per Share | Quarterly Revenue Growth 0.186 | Return On Assets |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.